Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Acute mental status changes caused by propranolol

N L Peters, K C Anderson, P R Reid

    The Johns Hopkins Medical Journal
    |November 1, 1978
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Small-scale density variations in the lunar crust revealed by GRAIL.

    Icarus·2020
    Same author

    Nucleotide excision repair is a potential therapeutic target in multiple myeloma.

    Leukemia·2017
    Same author

    Blockade of deubiquitylating enzyme Rpn11 triggers apoptosis in multiple myeloma cells and overcomes bortezomib resistance.

    Oncogene·2017
    Same author

    Second primary malignancies in multiple myeloma: an overview and IMWG consensus.

    Annals of oncology : official journal of the European Society for Medical Oncology·2017
    Same author

    HDAC3 regulates DNMT1 expression in multiple myeloma: therapeutic implications.

    Leukemia·2017
    Same author

    KDM6B modulates MAPK pathway mediating multiple myeloma cell growth and survival.

    Leukemia·2017
    Same journal

    An approach to the management of dementia syndromes.

    The Johns Hopkins medical journal·1982
    Same journal

    Torsion dystonia.

    The Johns Hopkins medical journal·1982
    Same journal

    The Rieger syndrome: a heritable disorder associated with glaucoma.

    The Johns Hopkins medical journal·1982
    Same journal

    Cerebro-hepato-renal (Zellweger) syndrome and neonatal adrenoleukodystrophy: similarities in phenotype and accumulation of very long chain fatty acids.

    The Johns Hopkins medical journal·1982
    Same journal

    Surgical therapy of complex partial epilepsy.

    The Johns Hopkins medical journal·1982
    Same journal

    Toxic epidermal necrolysis.

    The Johns Hopkins medical journal·1982
    See all related articles

    Low-dose propranolol can cause disorientation and paranoid delusions in elderly patients with dementia. Symptoms recurred upon rechallenge, indicating a direct link between the medication and adverse mental status changes.

    Area of Science:

    • Geriatric Medicine
    • Psychopharmacology
    • Neurology

    Background:

    • Beta-blockers like propranolol are commonly prescribed for various cardiovascular conditions.
    • Elderly patients, particularly those with cognitive impairments such as dementia, may exhibit unique responses to medications.
    • Understanding medication side effects in this vulnerable population is crucial for safe and effective treatment.

    Observation:

    • A 74-year-old female patient with pre-existing mild dementia experienced acute disorientation and paranoid delusions.
    • These neuropsychiatric symptoms emerged during treatment with low-dose propranolol.
    • No signs of cardiovascular compromise were noted during the adverse event.

    Findings:

    • The patient's mental status changes resolved spontaneously within one week of discontinuing propranolol.

    Related Experiment Videos

  • A subsequent rechallenge with propranolol resulted in the recurrence of disorientation and paranoid delusions.
  • This strongly suggests propranolol-induced neuropsychiatric effects in this patient.
  • Implications:

    • Clinicians should exercise caution when prescribing propranolol to elderly patients with dementia.
    • Careful monitoring for central nervous system side effects is warranted in this demographic.
    • This case highlights the potential for low-dose propranolol to trigger significant cognitive and psychiatric disturbances, necessitating a thorough risk-benefit assessment.